메뉴 건너뛰기




Volumn 24, Issue 1, 2013, Pages 97-104

IgG-enzyme fusion protein: Pharmacokinetics and anti-drug antibody response in rhesus monkeys

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; ENZYME ACTIVITY; IMMUNE SYSTEM; INSULIN; MAMMALS; MONOCLONAL ANTIBODIES; RECOMBINANT PROTEINS; TISSUE; TOXICITY;

EID: 84872588784     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3005123     Document Type: Article
Times cited : (30)

References (23)
  • 1
    • 84855597543 scopus 로고    scopus 로고
    • Re-engineering biopharmaceuticals for targeted delivery across the blood-brain barrier
    • Pardridge, W. M. and Boado, R. J. (2012) Re-engineering biopharmaceuticals for targeted delivery across the blood-brain barrier Methods Enzymol. 503, 269-92
    • (2012) Methods Enzymol. , vol.503 , pp. 269-292
    • Pardridge, W.M.1    Boado, R.J.2
  • 2
    • 84860710411 scopus 로고    scopus 로고
    • Immunogenicity to therapeutic proteins: Impact on PK/PD and efficacy
    • Chirmule, N., Jawa, V., and Meibohm, B. (2012) Immunogenicity to therapeutic proteins: impact on PK/PD and efficacy AAPS J. 14, 296-302
    • (2012) AAPS J. , vol.14 , pp. 296-302
    • Chirmule, N.1    Jawa, V.2    Meibohm, B.3
  • 3
    • 38449110954 scopus 로고    scopus 로고
    • Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
    • Boado, R. J., Zhang, Y., Xia, C. F., Wang, Y., and Pardridge, W. M. (2008) Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier Biotechnol. Bioeng. 99, 475-84
    • (2008) Biotechnol. Bioeng. , vol.99 , pp. 475-484
    • Boado, R.J.1    Zhang, Y.2    Xia, C.F.3    Wang, Y.4    Pardridge, W.M.5
  • 4
    • 69949114874 scopus 로고    scopus 로고
    • Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery
    • Pardridge, W. M. and Boado, R. J. (2009) Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery Pharm. Res. 26, 227-36
    • (2009) Pharm. Res. , vol.26 , pp. 227-236
    • Pardridge, W.M.1    Boado, R.J.2
  • 5
    • 0025826050 scopus 로고
    • Lysosomal storage diseases
    • Neufeld, E. F. (1991) Lysosomal storage diseases Annu. Rev. Biochem. 60, 257-80
    • (1991) Annu. Rev. Biochem. , vol.60 , pp. 257-280
    • Neufeld, E.F.1
  • 7
    • 0035000479 scopus 로고    scopus 로고
    • Enzyme replacement therapy in mucopolysaccharidosis type I: Progress and emerging difficulties
    • Wraith, J. E. (2001) Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties J. Inherit. Metab. Dis. 24, 245-50
    • (2001) J. Inherit. Metab. Dis. , vol.24 , pp. 245-250
    • Wraith, J.E.1
  • 8
    • 16844384688 scopus 로고    scopus 로고
    • Enzyme replacement therapy in mucopolysaccharidosis type i
    • discussion 57.
    • Miebach., E. (2005) Enzyme replacement therapy in mucopolysaccharidosis type I Acta Paediatr. Suppl. 94, 58-60 discussion 57.
    • (2005) Acta Paediatr. , vol.94 , pp. 58-60
    • Miebach, E.1
  • 9
    • 79961050726 scopus 로고    scopus 로고
    • Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein
    • Boado, R. J., Hui, E. K., Lu, J. Z., Zhou, Q. H., and Pardridge, W. M. (2011) Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein Mol. Pharm. 8, 1342-50
    • (2011) Mol. Pharm. , vol.8 , pp. 1342-1350
    • Boado, R.J.1    Hui, E.K.2    Lu, J.Z.3    Zhou, Q.H.4    Pardridge, W.M.5
  • 10
    • 70350236476 scopus 로고    scopus 로고
    • AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in rhesus monkeys
    • Boado, R. J., Hui, E. K., Lu, J. Z., and Pardridge, W. M. (2009) AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in rhesus monkeys J. Biotechnol. 144, 135-41
    • (2009) J. Biotechnol. , vol.144 , pp. 135-141
    • Boado, R.J.1    Hui, E.K.2    Lu, J.Z.3    Pardridge, W.M.4
  • 11
    • 0037260746 scopus 로고    scopus 로고
    • Evaluation of large-sized brains for neurotoxic endpoints
    • Garman, R. H. (2003) Evaluation of large-sized brains for neurotoxic endpoints Toxicol. Pathol. 31 (Suppl) 32-43
    • (2003) Toxicol. Pathol. , vol.31 , Issue.SUPPL. , pp. 32-43
    • Garman, R.H.1
  • 12
    • 53849119826 scopus 로고    scopus 로고
    • Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase)
    • White, J. T., Martell, L. A., Van Tuyl, A., Boyer, R., Warness, L., Taniguchi, G. T., and Foehr, E. (2008) Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase) AAPS J. 10, 363-72
    • (2008) AAPS J. , vol.10 , pp. 363-372
    • White, J.T.1    Martell, L.A.2    Van Tuyl, A.3    Boyer, R.4    Warness, L.5    Taniguchi, G.T.6    Foehr, E.7
  • 14
    • 33845930317 scopus 로고    scopus 로고
    • Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: Relationship to pharmacokinetics in mice and primates
    • Datta-Mannan, A., Witcher, D. R., Tang, Y., Watkins, J., Jiang, W., and Wroblewski, V. J. (2007) Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates Drug Metab. Dispos. 35, 86-94
    • (2007) Drug Metab. Dispos. , vol.35 , pp. 86-94
    • Datta-Mannan, A.1    Witcher, D.R.2    Tang, Y.3    Watkins, J.4    Jiang, W.5    Wroblewski, V.J.6
  • 16
    • 79952073057 scopus 로고    scopus 로고
    • Safety evaluation of biological drugs: What are toxicology studies in primates telling us?
    • Baldrick, P. (2011) Safety evaluation of biological drugs: what are toxicology studies in primates telling us? Regul. Toxicol. Pharmacol. 59, 227-36
    • (2011) Regul. Toxicol. Pharmacol. , vol.59 , pp. 227-236
    • Baldrick, P.1
  • 19
    • 84866457004 scopus 로고    scopus 로고
    • Glycemic control and chronic dosing of rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor
    • Boado, R. J., Hui, E. K., Lu, J. Z., and Pardridge, W. M. (2012) Glycemic control and chronic dosing of rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor Drug Metab. Dispos. 40, 2021-2025
    • (2012) Drug Metab. Dispos. , vol.40 , pp. 2021-2025
    • Boado, R.J.1    Hui, E.K.2    Lu, J.Z.3    Pardridge, W.M.4
  • 23
    • 79959444718 scopus 로고    scopus 로고
    • Chronic dosing of mice with a transferrin receptor monoclonal antibody-GDNF fusion protein
    • Zhou, Q. H., Boado, R. J., Lu, J. Z., Hui, E. K., and Pardridge, W. M. (2011) Chronic dosing of mice with a transferrin receptor monoclonal antibody-GDNF fusion protein Drug Metab. Dispos. 39, 1149-54
    • (2011) Drug Metab. Dispos. , vol.39 , pp. 1149-1154
    • Zhou, Q.H.1    Boado, R.J.2    Lu, J.Z.3    Hui, E.K.4    Pardridge, W.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.